Should You Buy Moderna Right Now?
Has (NASDAQ: MRNA) finally bottomed out? You may be asking that yourself right now, as shares in the biotech company have held steady at around $25 per share over the past six months.
Moderna might be a shell of its former self, no longer making billions from its COVID-19 vaccine, but it's still sitting on billions of dollars in capital. The company also has many promising candidates in its drug development pipeline.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€21.25
0.620%
With 10 Buy predictions and 9 Sell predictions the community is currently undecided on Moderna Inc..
Based on the current price of 21.25 € the target price of 60 € shows a potential of 182.42% for Moderna Inc. which would more than double the current price.
